康辰藥業(603590.SH):擬延長非公開發行股票決議有效期及授權有效期
格隆匯2月28日丨康辰藥業(603590.SH)公佈,鑑於公司實施非公開發行相關工作仍在持續推進中,而本次非公開發行股票的決議有效期、股東大會授權董事會全權辦理本次非公開發行股票相關事宜的有效期即將屆滿。為確保本次非公開發行股票工作順利推進,公司於2022年2月28日召開第三屆董事會第二十四次會議和第三屆監事會第二十二次會議,審議通過了《關於延長非公開發行A股股票股東大會決議有效期的議案》、《關於提請股東大會延長授權董事會全權辦理2021年度非公開發行A股股票相關事宜有效期的議案》,同意提請股東大會審議批准2021年度非公開發行A股股票股東大會決議有效期及授權董事會全權辦理2021年度非公開發行A股股票相關事宜的有效期自屆滿之日起延長12個月,即延長至2023年3月16日。除延長非公開發行股票項目股東會決議有效期及授權董事會有效期外,2021年度非公開發行股票的其他事項均未發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.